ISS: Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers

A CME Virtual Satellite Symposium in conjunction with the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer® Webinar Series.

Join Dr. Neil Love and a panel of gynecologic oncology clinical investigators as they discuss the current and future role of immune checkpoint inhibitors and other novel therapies in the management of ovarian, cervical and endometrial cancer. This interactive webinar will include polling, case studies and panel discussions as well as questions from the audience throughout the program.

1.5 AMA PRA Category 1 Credits™

REGISTER

A link to the event will be provided after registration.

Faculty

Michael J Birrer, MD, PhD
Director, Winthrop P Rockefeller Cancer Institute
Director, Cancer Service Line, University of Arkansas, Little Rock, AR

Ursula Matulonis, MD
Chief, Division of Gynecologic Oncology
Brock-Wilson Family Chair, Dana-Farber Cancer Institute, Boston, MA
Professor of Medicine, Harvard Medical School, Boston, MA

David M. O’Malley, MD
Professor
Division Director, Gynecologic Oncology
Co-Director, Gynecologic Oncology Phase I Program
The Ohio State University and the James Cancer Center, Columbus, OH

Krishnansu S. Tewari, MD
Professor and Division Director
Division of Gynecologic Oncology, University of California, Irvine, Irvine, CA

Moderator

Neil Love, MD
Research To Practice, Miami, FL

SGO does not offer CE for any of the Industry Sponsored Symposia. The offering of ISS does not constitute endorsement by the SGO of the information, products or services contained therein.

Top